 |
ST1-RTA immunotoxin (SR 44163) |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of acute graft versus host disease in allogenic bone marrow transplantation |
| USA Market Approval | USA |
| USA Designation Date | 1987-08-12 00:00:00 |
| Sponsor | Sanofi Winthrop, Inc.;9 Great Valley Parkway;Malvern, PA, 19355 |
